HC Wainwright Has Bearish Estimate for EYPT Q1 Earnings
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2025 EPS estimates for EyePoint Pharmaceuticals in a research note issued on Thursday, March 6th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of ($0.63) per share for the quarter, down from their previous […]
